Evaluation of SiO2 sonogels, prepared by a new catalyst-free method, as drug delivery system

Drug Delivery

Volumn 15, Issue 6, 2008, Pages 399-407

  Pinon Segundo, Elizabeth ^a   Ganem Quintanar, Adriana ^a   Flores Flores, Jose Ocotlan ^b   Saniger Blesa, Jose Manuel ^b   Urban Morlan, Maria Zaida ^a   Mendoza Romero, Luis ^a   Nava Arzaluz, Maria Guadalupe ^a   Quintanar Guerrero, David ^a,c  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^c NONE   (Mexico)

Author keywords

Delivery Systems; Silica; Silicon Dioxide; Sol Gel Technique; Sonogels; Xerogels

Indexed keywords

DYE; SILICON DIOXIDE; TETRAETHOXYSILANE;

ARTICLE; CATALYST; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; DRUG RELEASE; ENCAPSULATION; FEASIBILITY STUDY; GEL; PARTICLE SIZE; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SYNTHESIS; TECHNIQUE;

CALORIMETRY, DIFFERENTIAL SCANNING; CAPSULES; CATALYSIS; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; GELS; MICROSCOPY, ELECTRON, SCANNING; SILICON DIOXIDE; TEMPERATURE;

EID: 49549114900     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.1080/10717540802039162     Document Type: Article

References (27)

1. Ahola, M., Kortesuo, P., Kangasniemi, I., Kiesvaara, J., and Yli-Urpo, A. 1999b. In vitro release behavior of toremifene citrate from sol-gel processed sintered silica xerogels. Drug Dev. Ind. Pharm. 25(8):955-959.
2. Ahola, M., Kortesuo, P., Kangasniemi, I., Kiesvaara, J., and Yli-Urpo, A. 2000. Silica xerogel carrier material for controlled release of toremifene citrate. Int. J. Pharm. 195:219-227.
3. Ahola, M., Rich, J., Kortesuo, P., Kiesvaara, J., Seppälä, J., and Yli-Urpo, A. 1999a. In vitro evaluation of biodegradable ε-caprolactone-co-D,L-lactide/silica xerogel composites containing toremifene citrate. Int. J. Pharm. 181:181-191.
4. Ahola, M., Säilynoja, E. S., Raitavuo, M., Vaahtio, M., Salonen, J., and Yli-Urpo, A. 2001. In vitro release of heparin from silica xerogels. Biomaterials 22:2163-2170.
5. Blanco, E., Esquivias, L., Litran, R., Pinero, M., Ramírez-del- Solar, M., and De la Rosa-Fox, N. 1999. Sonogels and derived materials. Applied Organomet. Chem. 13:399-418.
6. Böttcher, H., Kallies, K. H., and Haufe, H. 1997. Model investigations of controlled release of bioactive compounds from thin metal oxide layers. J. Sol-Gel Sci. Technol. 8:651-654.
7. Böttcher, H., Slowik, P., and Süß, W. 1998. Sol-gel carrier systems for controlled drug delivery. J. Sol-Gel Sci. Technol. 13:277-281.
8. Higuchi, T. 1961. Rate of release of medicaments from ointment base containing drug in suspension. J. Pharm. Sci. 50:874-875.
9. Kortesuo, P., Ahola, M., Kangas, M., Jokinen, M., Leino, T., Vuorilehto, L., Laakso, S., Kiesvaara, J., Yli-Urpo, A., and Marvola, M. 2002. Effect of synthesis parameters of the sol-gel processed spray-dried silica gel microparticles on the release rate of dexmedetomidine. Biomaterials 23:2795-2801.
10. Kortesuo, P., Ahola, M., Kangas, M., Kangasniemi, I., Yli-Urpo, A., and Kiesvaara, J. 2000b. In vitro evaluation of sol-gel processed spray dried silica gel microspheres as carrier in controlled drug delivery. Int. J. Pharm. 200:223-229.
11. Kortesuo, P., Ahola, M., Kangas, M., Leino, T., Laakso, S., Vuorilehto, L., Yli-Urpo, A., Kiesvaara, J., and Marvola, M. 2001b. Alkyl-substituted silica gel as a carrier in the controlled release of dexmedetomidine. J. Control. Release 76:227-238.
12. Kortesuo, P., Ahola, M., Kangas, M., Yli-Urpo, A., Kiesvaara, J., and Marvola, M. 2001a. In vitro release of dexmedetomidine from silica xerogel monoliths: effect of sol-gel synthesis parameters. Int. J. Pharm. 221:107-114.
13. Kortesuo, P., Ahola, M., Karlsson, S., Kangasniemi, I., Yli-Urpo, A., and Kiesvaara, J. 2000a. Silica xerogel as an implantable carrier for controlled drug delivery - evaluation of drug distribution and tissue effects after implantation. Biomaterials 21:193-198.
14. Levy, M. Y., and Benita, S. 1990. Drug release from submicronized o/w emulsion, a new in vitro kinetic evaluation model. Int. J. Pharm. 66:29-37.
15. Maver, U., Godec, A., Bele, M., Planinsek, O., Gaberscek, M., Srcic, S., and Jamnik, J. 2007. Novel hybrid silica xerogels for stabilization and controlled release of drug. Int. J. Pharm. 330:164-174.
16. Ocotlán-Flores, J., and Saniger, J. M. 2006. Catalyst-free sonogels. J. Sol-Gel Sci. Technol. 39:235-240.
17. Piñón-Segundo, E., Ganem-Quintanar, A., Alonso-Pérez, V., and Quintanar-Guerrero, D. 2005. Preparation and characterization of triclosan nanoparticles for periodontal treatment. Int. J. Pharm. 294:217-232.
18. Ritger, P. L., and Peppas, N. A. 1987. A simple equation for description of solute release. I. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres and cylinders or disks. J. Control. Release 5:23-36.
19. Setzer, C., van Essche, G., and Pryor, N. 2002. Other oxides. In Handbook of Porous Solids, Vol. 4, ed. Ferdi Schüt, Kenneth S.W. Sing, and Jens Weitkamp, 1554-1555. Federal Republic of Germany: Wiley-VCH.
20. Siepmann, J., and Peppas, N.A. 2001. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose HPMC. Adv. Drug Deliv. Rev. 48:139-157.
21. Unger, K., Rupprecht, H., Valentin, B., and Kircher, W. 1983. The use of porous and surface modified sílicas as drug delivery and stabilizing agents. Drug Dev. Ind. Pharm. 9(1):69-91.
22. Vitala, R., Jokinen, M., Tuusa, S., Rosenholm, J. B., and Jalonen, H. 2005. Adjustably Bioresorbable sol-gel derived SiO2 matrices for release of large biologically active molecules. J. Sol-Gel Sci. Technol. 36:147-156.
23. Vollet, D. R., Donatti, D.A., Ibañez Ruiz, A., and De Castro, W. C. 2003. Structural study of aged satured silica gels obtained from tetramethoxysilane sonohydrolysis with different water/ tetramethoxysilane molar ratio. Phys. Rev. B 67:184207/1-184207/5.
24. Wade, A., and Weller, P. J. ed. 1994. Handbook of Pharmaceutical Excipients, Vol. 1. Washington: American Pharmaceutical Association.
25. Wu, Z., Joo, H., Ahn, I.-S., Kim, J.-H., Kim, C.-K., and Lee, K. 2004. Design of doped hybrid xerogels for a controlled release of brilliant blue FCF. J. Non-Crys. Solids 342:46-53.
26. Wu, Z., Joo, H., Lee, T.G., and Lee, K. 2005. Controlled release of lidocaine hydrochloride from the surfactant-doped hybrid xerogels. J. Control. Rel. 104:497-505.
27. Zarzycki, J. 1994. Heterogen. Chem. Rev. 1:243-253.